Greg Abel-Led Berkshire Hathaway Owns 26 Dividend Stocks. Here's the One I'd Buy First.

Constellation Brands’ latest-quarter revenue fell 3% year over year, while adjusted EPS rose about 7% to $3.43; operating cash flow increased 4% to $662 million and free cash flow rose 9% to $485 million. The company pays a quarterly dividend of $1.03 per share, yielding 3.64%, and the article cites a 34% payout ratio and 10 consecutive years of dividend increases. Shares were down 19% year to date at $113; 62% of analysts rated the stock a buy, with a $173.50 median price target, implying about 54% upside.

Analysis

The setup is a potential value trap, not yet a demonstrated turnaround. STZ’s earnings and cash-flow resilience may reflect portfolio pruning and mix rather than a recovery in underlying beer demand. If volumes continue to contract, pricing and cost actions can support reported profit temporarily while weakening brand momentum, retailer leverage, and the earnings base behind the apparent low multiple. The key competitive risk is shelf-space substitution toward domestic beer and other beverage choices; larger rivals such as Molson Coors and Anheuser-Busch InBev may be better placed to absorb category softness, though their exposure differs.

Near term, the article itself is unlikely to change fundamentals. Over the next 1–3 months, focus on the next report’s depletion versus shipment trends, beer volume and price/mix, guidance, and whether free cash flow covers both the dividend and investment needs. Tariffs or packaging-cost relief could help margins, but would not resolve weak consumer demand. Over 6–18 months, sustained changes in alcohol consumption and the Hispanic consumer backdrop are more consequential than the current yield or analyst targets. Those targets are not a catalyst and should not substitute for a volume recovery.

Contrarian view: the yield and low earnings multiple may overstate downside protection if earnings are not normalized and cash generation is helped by divestitures or working-capital timing. The thesis improves only if core beer volumes stabilize without relying on heavier discounting. A continued deterioration in depletions, a guidance cut, or dividend coverage weakening would falsify the recovery case.

Key Decisions for Investors

• Do not chase STZ solely on the cited yield or upside-to-consensus target. Keep it on watch pending evidence that consumer demand and beer depletion trends are stabilizing.
• At the next earnings release, compare shipments with depletions, volume with price/mix, and free cash flow with dividend payments; verify whether reported cash generation is recurring after portfolio changes.
• If volumes stabilize and guidance holds, consider a staged long in STZ rather than buying ahead of confirmation. Thesis risk: renewed volume declines or discounting that erodes margins; reassess on a guidance reduction or weaker dividend coverage.
• No high-conviction pair trade is supported by the article alone. Before positioning against KO or beer competitors, verify relative valuation, category exposure, and current operating trends.